Featured Publications
The Zero Suicide Model in Addiction Treatment Settings: Recognizing the Need for Feasibility and Implementation Data
Arakelian M, Barnett B, Weleff J. The Zero Suicide Model in Addiction Treatment Settings: Recognizing the Need for Feasibility and Implementation Data. Psychiatric Services 2023, 75: 378-380. PMID: 37933133, DOI: 10.1176/appi.ps.20230175.Peer-Reviewed Original ResearchConceptsAddiction treatment settingsTreatment settingsZero SuicideSubstance use disordersZero Suicide modelAddiction outcomesUse disorderSuicide modelsAddiction treatmentHealth care settingsAddictionHealth care systemSuicide preventionSuicideImplement best practicesCare settingsCare systemOpen ForumIncreased riskBest practicesHealthDisordersSetsResearchClinicians
2024
Changes in Emergency Department Utilization in Vulnerable Populations After COVID-19 Shelter-in-Place Orders
Wang P, Anand A, Bena J, Morrison S, Weleff J. Changes in Emergency Department Utilization in Vulnerable Populations After COVID-19 Shelter-in-Place Orders. Cureus 2024, 16: e60556. PMID: 38887338, PMCID: PMC11182374, DOI: 10.7759/cureus.60556.Peer-Reviewed Original ResearchSocial determinants of healthSubstance use disordersElectronic medical recordsED utilizationEmergency departmentMH disordersDocumenting social determinants of healthMental healthVulnerable populationsDeterminants of healthRate of hospital admissionsEmergency department utilizationHistory of mental healthIntegrated healthcare systemMedical recordsCompare emergency departmentShelter-in-placeIncreased ED utilizationLogistic regression modelsCOVID-19 shelter-in-placePatients' medical recordsED careSocial determinantsPublic health crisisZ codesAmerican Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey
Barnett B, Arakelian M, Beebe D, Ontko J, Riegal C, Siu W, Weleff J, Pope H. American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey. Psychedelic Medicine 2024, 2: 1-9. DOI: 10.1089/psymed.2023.0036.Peer-Reviewed Original ResearchSubstance use disordersAmerican psychiatristsClassic hallucinogensPsychiatric conditionsTreatment-resistant depressionTreat psychiatric conditionsMultivariate logistic regression modelFollow-up surveyResponding psychiatristsPsychiatrists' opinionsTherapeutic potentialLogistic regression modelsUnited States Food and Drug AdministrationStates Food and Drug AdministrationHallucinogensPsychiatristsFood and Drug AdministrationPublished national surveysIncreased optimismDecreased concernAssessment attributesSurvey responsesNon-parametric trend testSurvey instrumentRegression models
2023
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
Barnett B, Nia A, Sackett N, Weleff J. Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges. Frontiers In Psychiatry 2023, 14: 1305478. PMID: 37928914, PMCID: PMC10622752, DOI: 10.3389/fpsyt.2023.1305478.Peer-Reviewed Original Research
2022
Psychedelics in the Treatment of Substance Use Disorders
Barnett B, Weleff J. Psychedelics in the Treatment of Substance Use Disorders. Psychiatric Annals 2022, 52: 365-370. DOI: 10.3928/00485713-20220804-01.Peer-Reviewed Original ResearchSubstance use disordersPsychedelic experienceTreatment of substance use disordersLysergic acid diethylamideSubjective effectsUse disorderAcid diethylamidePlacebo-controlled trialPsychedelicsBehavioral changesTherapeutic potentialClinician concernsLife narrativesDisordersFacilitation programTreatment paradigmTherapeutic efficacyClinical trialsTreatment potentialObservational studyPsilocybinDiethylamideTrialsSubstancesOpioidReported firearm access among patients admitted to a dual diagnosis medically-assisted withdrawal unit over five years
Weleff J, Butler R, Streem D, Barnett B. Reported firearm access among patients admitted to a dual diagnosis medically-assisted withdrawal unit over five years. Drug And Alcohol Dependence Reports 2022, 2: 100034. PMID: 36845895, PMCID: PMC9949337, DOI: 10.1016/j.dadr.2022.100034.Peer-Reviewed Original ResearchFirearm accessLogistic regression modelsMultivariate logistic regression modelFirearm-related suicidesSuicide risk assessmentSubstance use disordersClinical relevancePatientsFirearmRegression modelsFirearm researchSuicidal ideationSuicide attemptsStatistical significanceDisorders unitGeneral populationAdmissionStudy periodAccess screeningBivariate analysisInpatient unitSuicideMarital statusDiagnosis unitYear period
2019
322 Resource Utilization for Patients Presenting to Emergency Department With Mental and Substance Use Disorders: National Hospital Ambulatory Medical Care Survey Analysis
Lopez R, Schold J, Weleff J, Phelan M. 322 Resource Utilization for Patients Presenting to Emergency Department With Mental and Substance Use Disorders: National Hospital Ambulatory Medical Care Survey Analysis. Annals Of Emergency Medicine 2019, 74: s126. DOI: 10.1016/j.annemergmed.2019.08.281.Peer-Reviewed Original Research